About This Webinar

NIH has released the Draft Biosafety Policy for Research Involving Biohazards for public comment. The proposal would replace the current NIH Guidelines and significantly reshape the scope, structure, and administration of institutional biosafety oversight.

BSAA members convened eight working groups of biosafety administrators and compliance professionals to examine assigned sections of the draft. This webinar will share their developing observations, practical concerns, and recommendations from the perspective of the professionals who may be responsible for implementing the policy. The primary goal of the webinar is to develop suggestive comments from the biosafety administrator’s community and provide them to the Office of Science Policy, NIH.

What the Working Groups Will Report

• How the proposed policy may change the scope of research requiring institutional oversight
• IBC structure, responsibilities, authority, and institutional governance expectations
• Research review categories, approval pathways, and investigator responsibilities
• Incident reporting, committee minutes, records, and documentation expectations
• Operational impact, staffing needs, implementation challenges, and areas needing clarification
• Recommendations and questions emerging from the biosafety administration community

Why Attend?

Participants will gain a practical, user-focused view of the draft policy and hear how biosafety administrators from different institutions are interpreting its potential requirements. The discussion will help institutions identify issues to evaluate now and contribute informed feedback while the policy remains under development.

Who Should Attend?

• Biosafety officers and biosafety professionals
• IBC administrators, chairs, and members
• Research compliance and environmental health and safety professionals
• Institutional officials, research leaders, and legal or policy partners
• Others responsible for implementing or supporting institutional biosafety oversight

Draft Policy and Public Comment

The draft policy and supporting materials are available through the NIH Office of Science Policy. Public comments are due October 19, 2026.

https://osp.od.nih.gov/policies/biosafety-and-biosecurity-policy/

Standing BSAA Faculty

Bill Greer

Assistant Vice President for Research, University of Michigan

Bill Greer is a nationally recognized leader in research compliance with more than 35 years of experience spanning academia, industry, and nonprofit professional organizations. At the University of Michigan, he oversees institutional programs for animal care and use, biosafety, laboratory safety, controlled substances, and emerging autonomous systems.

Bill began his career in industry as a production manager and safety director at Intervet (formerly Tri Bio Laboratories) before transitioning to higher education, where he has held senior roles including Associate Director for Research Compliance, IACUC Vice-Chair, and Biosafety Committee Chair at The Pennsylvania State University. He earned his degree in Microbiology from The Pennsylvania State University.

In 2005, Bill founded the Research Administrators’ Best Practice Meetings, creating a nationally respected forum for research oversight professionals to address real-world programmatic challenges. He continues to facilitate multiple Best Practice Meetings annually focused on biosafety and animal care and use programs.

Bill also chaired the founding committee of the IACUC Administrators Association (IAA) in 2010 and continues to serve as its president and board chair. Since 2007, he has served as an ad hoc consultant to AAALAC International, conducting institutional program reviews and assessments. A frequent speaker and educator, Bill regularly presents at PRIM&R, AALAS, BTAA, C3, and BSAA-sponsored programs, supporting both IBC and IACUC administrative communities nationwide.

Jonah Lee, PhD

Senior Associate Director, University of Michigan

Dr. Jonah Lee brings deep scientific expertise and administrative leadership to biosafety and animal research oversight, with a strong focus on enhancing researcher experience while maintaining regulatory rigor. In his role at the University of Michigan, he provides thought leadership, program oversight, and process optimization across the Animal Care & Use Program.

Working closely with research administration and academic leadership, Dr. Lee leads the strategic development of research engagement infrastructure and institutional support resources. His background in biomedical sciences includes extensive research in stem cell biology and regenerative medicine, with a focus on aging skeletal muscles.

Dr. Lee completed postdoctoral training at the Center for Muscle Biology at the University of Kentucky and has led federally funded research involving both small and large animal models across multiple departments. His combined experience as a scientist and administrator brings a practical, researcher-informed perspective to biosafety and compliance discussions.

Andrew Maksymowych, PhD

Associate Director, Biosafety Programs, University of Pennsylvania

Andrew Maksymowych has more than three decades of experience in research, teaching, and biosafety oversight. Since 2006, he has served at the University of Pennsylvania as Associate Director for Biological Safety Programs, Institutional Biosafety Officer, IBC Administrator, and Institutional Contact for Dual Use Research.

Andrew serves on multiple institutional advisory committees, including the Vice Provost for Research Human Research Advisory Committee, the Human Stem Cell Research Advisory Committee, and the Cadaver and Body Parts Oversight Committee. He holds a B.S. and M.S. from Villanova University and a PhD in Biochemistry from Bryn Mawr College.

Prior to Penn, Andrew held a faculty appointment at Thomas Jefferson University, where his research focused on protein structure-function relationships, including neurotoxins affecting the human nervous system - most notably botulinum neurotoxins. An active BSAA contributor since attending his first Best Practice Meeting in 2015, Andrew remains deeply engaged in advancing biosafety education and professional collaboration.

Raymond F. Scheetz, MS, RBP

Institutional Biosafety Officer & Compliance Manager, Penn State College of Medicine

Ray Scheetz serves as Institutional Biosafety Officer and Compliance Manager at the Penn State College of Medicine within the Research Quality Assurance Office. He oversees all aspects of biosafety compliance, including protocol reviews, biosafety training, annual laboratory surveys, emergency response coordination, and equipment and asset management.

Ray is an active member of the Institutional Biosafety Committee, Research Mission Team, and institutional research emergency task forces. In addition to his institutional role, he serves as a biosafety consultant for Clinical Biosafety Services (CBS) / Shield Consulting.

Previously, Ray spent 25 years as a Laboratory Manager in the Department of Microbiology and Immunology at Penn State College of Medicine, where he managed a BSL-3 facility and supported complex infectious disease research programs. His extensive operational experience provides a grounded, practical perspective on biosafety program implementation.

The webinar will be held at 3:00 PM Eastern Time.